Literature DB >> 21329861

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.

Ian G Stiell1, Laurent Macle.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia managed by emergency physicians. There is increasing evidence that most patients with recent-onset AF or atrial flutter (AFL) can be safely managed in the emergency department (ED) without the need for hospital admission. The priorities for ED management of recent-onset AF/AFL include rapid assessment of potential hemodynamic instability and identification and treatment of the underlying or precipitating cause. A careful evaluation of the patient's history should be performed to determine the time of onset of the arrhythmia. All patients should be stratified using a predictive index for the risk of stroke (eg, CHADS(2)). For stable patients with recent-onset AF/AFL, a strategy of either rate control or rhythm control could be selected based on multiple factors including the duration of AF and the severity of symptoms. If a strategy of rhythm control has been selected, either electrical or pharmacologic cardioversion may be used. Before proceeding to cardioversion in the absence of systemic anticoagulation, physicians must be confident that the duration of AF/AFL is clearly <48 hours and that the patient is not at a particularly high risk of stroke. When the duration of AF/AFL is >48 hours or uncertain, rate control should be optimized first and the patients should receive therapeutic anticoagulation for 3 weeks before and 4 weeks after planned cardioversion. Adequate follow-up of patients with recent-onset AF/AFL is recommended to identify structural heart disease and evaluate the need for long-term antithrombotic or antiarrhythmic therapy.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329861     DOI: 10.1016/j.cjca.2010.11.014

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  15 in total

Review 1.  Epidemiology and prevention of stroke: a worldwide perspective.

Authors:  Elena V Kuklina; Xin Tong; Mary G George; Pooja Bansil
Journal:  Expert Rev Neurother       Date:  2012-02       Impact factor: 4.618

2.  Incident atrial fibrillation in the emergency department in Ontario: a population-based retrospective cohort study of follow-up care.

Authors:  Clare L Atzema; Bing Yu; Noah Ivers; Paula Rochon; Douglas S Lee; Michael J Schull; Peter C Austin
Journal:  CMAJ Open       Date:  2015-04-02

3.  Guidelines on the management of atrial fibrillation in the emergency department: a critical appraisal.

Authors:  Giorgio Costantino; Gian Marco Podda; Lorenzo Falsetti; Primiano Iannone; Ana Lages; Alberto M Marra; Maristella Masala; Olaug Marie Reiakvam; Florentia Savva; Jan Schovanek; Sjoerd van Bree; Inês João da Silva Chora; Graziella Privitera; Silvio Ragozzino; Matthias von Rotz; Lycke Woittiez; Christopher Davidson; Nicola Montano
Journal:  Intern Emerg Med       Date:  2016-11-30       Impact factor: 3.397

Review 4.  Managing atrial fibrillation.

Authors:  Clare L Atzema; Tyler W Barrett
Journal:  Ann Emerg Med       Date:  2015-02-18       Impact factor: 5.721

5.  Emergency department procedural sedation for primary electrical cardioversion - a comparison with procedural sedations for other reasons.

Authors:  Michael Butler; Patrick Froese; Peter Zed; George Kovacs; Robert MacKinley; Kirk Magee; Mary-Lynn Watson; Samuel G Campbell
Journal:  World J Emerg Med       Date:  2017

6.  The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study.

Authors:  Paul Angaran; Zara Mariano; Vlad Dragan; Lily Zou; Clare L Atzema; Iqwal Mangat; Paul Dorian
Journal:  J Atr Fibrillation       Date:  2015-02-28

7.  Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.

Authors:  Antonio Bonora; Gianni Turcato; Elena Franchi; Gabriele Taioli; Alice Dilda; Germana Zerman; Antonio Maccagnani; Claudio Pistorelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2016-07-06       Impact factor: 3.397

8.  Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the United States.

Authors:  Bory Kea; Benjamin C Sun; David R Vinson
Journal:  Can J Cardiol       Date:  2018-03-31       Impact factor: 5.223

Review 9.  Management and Disposition of Atrial Fibrillation in the Emergency Department: A Systematic Review.

Authors:  Justin L Vandermolen; Murrium I Sadaf; Anil K Gehi
Journal:  J Atr Fibrillation       Date:  2018-06-30

10.  Validation of a decision rule for selective TSH screening in atrial fibrillation.

Authors:  Shawna D Bellew; Rajat Moman; Christine M Lohse; Erik P Hess; M Fernanda Bellolio
Journal:  West J Emerg Med       Date:  2015-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.